Six new comedications have been added to the interaction checker, taking the total number of comedications to nearly 720. The new comedications and their therapeutic classes are shown below:
- Acamproasate (Other)
- Adalimumab (Immunosuppressants)
- Cannabidiol (Other)
- Cetuximab (Cancer Therapies)
- Evolocumab (Lipid Lowering Agents)
- Vortioxetine (Antidepressants)
